SOC Telemed, Inc. (TLMD): Price and Financial Metrics
TLMD Price/Volume Stats
| Current price | $3.00 | 52-week high | $8.00 |
| Prev. close | $3.00 | 52-week low | $0.55 |
| Day low | $2.99 | Volume | 957,600 |
| Day high | $3.00 | Avg. volume | 1,277,212 |
| 50-day MA | $2.61 | Dividend yield | N/A |
| 200-day MA | $2.73 | Market Cap | 302.52M |
TLMD Stock Price Chart Interactive Chart >
SOC Telemed, Inc. (TLMD) Company Bio
SOC Telemed, Inc. provides acute care telemedicine services. The Company offers patient-focused telemedicine solutions. SOC Telemed serves patients in the United States.
Latest TLMD News From Around the Web
Below are the latest news stories about SOC Telemed Inc that investors may wish to consider to help them evaluate TLMD as an investment opportunity.
What Type Of Shareholders Own The Most Number of SOC Telemed, Inc. (NASDAQ:TLMD) Shares?The big shareholder groups in SOC Telemed, Inc. ( NASDAQ:TLMD ) have power over the company. Generally speaking, as a... |
SOC Telemed inks a deal to go private — just 15 months after it first went public via a SPAC dealThe telemedicine company has had a whirlwind year with multiple leadership changes and an internal restructuring with layoffs and other cuts. |
MP Stock: 15 Things to Know About the Short Report Stinging EV Play MP MaterialsMP Materials (MP) stock is taking a beating on Thursday thanks to a new short report calling out the electric vehicle (EV) play. |
SOC Telemed to be Acquired by Patient Square CapitalSOC Telemed, Inc. (NASDAQ: TLMD) (the "Company" or "SOC Telemed"), the largest national provider of acute care telemedicine, today announced that it has entered into a definitive agreement to be acquired by Patient Square Capital ("Patient Square"), the leading dedicated health care investment firm. |
Robert W. Baird Thinks SOC Telemed’s Stock is Going to RecoverIn a report issued on November 15, Vikram Kesavabhotla from Robert W. Baird maintained a Buy rating on SOC Telemed (TLMD – Research Report), with a price target of $4.00. The company's shares closed last Wednesday at $2.14, close to its 52-week low of $1.86. According to TipRanks.com, Kesavabhotla has currently 0 stars on a ranking scale of 0-5 stars, with an average return of -6.7% and a 41.7% success rate. Kesavabhotla covers the Technology sector, focusing on stocks such as Definitive Healthcare Corp, Tabula Rasa HealthCare, and InnovAge Holding. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for SOC Telemed with a $5. |
TLMD Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | -57.14% |
| 5-year | N/A |
| YTD | N/A |
| 2023 | N/A |
| 2022 | 0.00% |
| 2021 | -83.67% |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...